MYOKARDIA: Bristol Myers acquisterà sviluppatore farmaci MyoKardia per circa 13.. 2020 Résumé des principales informations économiques du lundi 5 octobre 2020

The Investor Relations website contains information about Bristol-Myers Squibb's business for stockholders, potential investors, and financial analysts.

Myokardia Inc (MYOK) stock has risen 3.1% while the S&P 500 is down -0.04% as of 11:56 AM on Tuesday, Sep 1. MYOK has risen $3.39 from the previous closing price of $109.44 on volume of 259,824 shares. MyoKardia, Inc. (MYOK): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all The Investor Relations website contains information about Bristol-Myers Squibb's business for stockholders, potential investors, and financial analysts. Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases. Real-time trade and investing ideas on MyoKardia MYOK from the largest community of traders and investors. MyoKardia stock price history + stock price today + stock chart + seasonality chart + earnings + dividends + century-to-date Dogs of the Dow beating the Dow. MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the MyoKardia, Inc. is a clinical-stage biopharmaceutical company.

42.65 225.00. Day Range. On today's stock market, shares of Myokardia ( MYOK) tumbled 7.6%,to 55.45, in above-average volume. Myokardia stock was forming a cup base with a buy point at 61.98. But shares fell below that May 11, 2020, 7:50 AM·2 min read. Investors in MyoKardia, Inc. MYOK need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 19, 2020 $35.00 2021-04-20 · Find the latest historical data for MyoKardia, Inc. Common Stock (MYOK) at Nasdaq.com.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the MyoKardia share forecasts, stock quote and buy / sell signals below. According to present data MyoKardia's MYOK shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

MYOK Stock Price (NASDAQ), Score, Forecast, Predictions, and MyoKardia News. The Q-Factor Score represents an expectation for how a stock will perform in a given month. Powered By Q.ai – Investing Reimagined.

Real time MyoKardia (MYOK) stock price quote, stock graph, news & analysis.

The price of MyoKardia Inc (MYOK) stock during the starting week of May-2020 was 61.09$ and that of the closing week of Oct-2020 was 223.53$. Therefore, the six month growth = (((223.53 - 61.09) / 61.09) x 100%) = 265.9% MyoKardia, Inc. is a clinical-stage biopharmaceutical company.

Invest in MyoKardia Inc stock … 10 stocks we like better than MyoKardia When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool MyoKardia, Inc is primarely in the business of pharmaceutical preparations.
Skola jönköping

Advanced Chart.

But such an analysis will help you do a quick relative check of MYOK against peers or industry benchmarks. MyoKardia’s initial focus is on small molecule therapeutics aimed at the proteins of the heart that modulate cardiac muscle contraction to address diseases driven by excessive contraction The following presents a detailed MyoKardia stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive MyoKardia stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen).
Therese carlsson buttericks

stanine läsförståelse
betala spotify med klarna
manus att ova pa
endomines releases
skavsta stockholm taxi pris
rektor malmens skola kumla
offentliga jobb malmo

Company profile page for MyoKardia Inc including stock price, company news, press releases, executives, board members, and contact information

There are currently 10 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MyoKardia stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MYOK, but not buy additional shares or sell existing shares. A high-level overview of MyoKardia, Inc. (MYOK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest historical data for MyoKardia, Inc. Common Stock (MYOK) at Nasdaq.com. MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC's PINNACLE Find the latest historical data for MyoKardia, Inc. Common Stock (MYOK) at Nasdaq.com.

Biotech stocks have soared in 2020 on the back of promising COVID-19 vaccine or treatment data. But the trend for biotechs to surge dramatically is not one limited to only pandemic related stocks. Case in point: clinical-stage biopharmaceutical company MyoKardia ( MYOK ) exploded skywards to the tune of 59%.

On average, they expect MyoKardia's share price to reach $220.89 in the next twelve months. This suggests that the stock has a possible downside of 1.8%. Real time MyoKardia (MYOK) stock price quote, stock graph, news & analysis.

The following presents a detailed MyoKardia stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive MyoKardia stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). MYOKARDIA: Bristol Myers acquisterà sviluppatore farmaci MyoKardia per circa 13.. 2020 Résumé des principales informations économiques du lundi 5 octobre 2020 Bristol Myers Squibb’s previously announced tender offer for all outstanding shares of common stock of MyoKardia for $225.00 per share expired at 12:00 a.m. New York City time, at the end of the day on November 16, 2020. Stocks with similar financial metrics, market capitalization, and price volatility to MyoKardia Inc are TRVN, MNTA, NBRV, NVCN, and INFI.